Anastomosis Devices Market Size (2024 - 2029)

The anastomosis devices market is projected to experience growth driven by an increase in surgical procedures such as colectomy and CABG, alongside advancements in technology and supportive reimbursement policies. The resumption of postponed surgeries post-pandemic has further contributed to market expansion. Additionally, the rising number of surgeries related to trauma, hip and knee replacements, and chronic diseases is a significant growth factor. Despite these positive trends, challenges such as the adoption of minimally invasive procedures, high treatment costs, and inadequate healthcare infrastructure may impede market growth.

Market Size of Anastomosis Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Anastomosis Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 7.00 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Anastomosis Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Anastomosis Devices Market Analysis

The anastomosis devices market is anticipated to register a CAGR of 7.0% during the forecast period.

The COVID-19 pandemic is an unprecedented health concern and adversely affects various surgical procedures. Due to regulatory authorities' strict guidance to prevent any non-emergent surgeries, the volume of surgeries has drastically decreased throughout the pandemic. According to the study published in October 2021 by the National Library of Medicine globally, there has been a 42.8% decrease in general surgery admissions. Thus, the reduction in the number of surgical procedures during the COVID-19 pandemic affected the market's growth. However, the postponed surgeries resumed worldwide, driving the market's growth during the post-pandemic period.

Factors such as the rise in several surgical procedures like colectomy, CABG, and others and the availability of technologically advanced products and reimbursement policies are boosting the growth of the market for anastomosis devices. For instance, according to an article published by StatPearls, in August 2022, almost 400,000 CABG surgeries are performed each year making it the most commonly performed major surgical procedure in United States. Additionally, according to the data published by the HSRA in March 2022, about 40,000 organ transplants were performed in the United States in 2021. In addition, 26,670 kidney transplants and 9,236 live transplants were performed in the United States in 2021. Thus, an increase in the surgical procedure is expected to increase the number of anastomosis devices demand, hence driving the market.

Moreover, the number of surgical procedures due to trauma, hip and knee replacements, and chronic diseases such as cardiovascular diseases where surgery is mandatory is growing. This is the primary growth factor for the anastomosis devices market. For instance, as per the research study published in June 2021 by the Journal of Thoracic and Cardiovascular Surgery, a total of 92,809 operations were classified as heart surgery procedures in the classical sense, of which 29,444 were isolated coronary artery bypass grafting procedures, 35,469 were isolated heart valve procedures, and the number of isolated heart transplantations increased by 2% to 340. Hence, the high number of heart procedures and operations being performed is expected to boost the growth of the anastomosis devices market.

Various initiatives taken by the key market players, such as product launches, mergers, acquisitions, and partnerships, are expected to boost the market's growth during the forecast period. For instance, in August 2021, Medicare Part B covers coronary artery bypass graft surgery, coronary angioplasty, valve repair & replacement, and other comprehensive Cardiac Rehabilitation (CR) programs. Also, In March 2021, Johnson & Johnson (US) launched the ECHELON+ Stapler, a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression and better staple formation. Such developments are expected to drive the growth of the market over the forecast period.

The above-mentioned factors are expected to drive the market's growth worldwide. However, the adoption of minimally invasive procedures like percutaneous coronary interventions and highly expensive treatments, and the lack of advanced healthcare infrastructure are expected to hamper the growth of the anastomosis devices market during the forecast period.

Anastomosis Devices Industry Segmentation

As per the report's scope, anastomosis is a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections. It is a critical step in surgery and has a high risk for complications, which requires highly efficient and advanced devices to perform. The anastomosis devices market is segmented by usage (disposable and reusable), type (surgical staplers, surgical sutures, surgical sealants and adhesives, and other types), application (cardiovascular surgery, gastrointestinal surgery, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD) for the above segments.

By Usage
Disposable
Reusable
By Type
Surgical Staplers
Surgical Sutures
Surgical Sealants and Adhesives
Other Types
By Application
Cardiovascular Surgery
Gastrointestinal Surgery
Others
Geography
North America
United states
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Anastomosis Devices Market Size Summary

The anastomosis devices market is poised for significant growth, driven by an increase in surgical procedures such as colectomy and coronary artery bypass grafting (CABG), alongside advancements in technology and supportive reimbursement policies. The market experienced a temporary setback during the COVID-19 pandemic due to a decrease in non-emergent surgeries, but has since rebounded as postponed procedures resumed. The rising prevalence of chronic diseases, including cardiovascular conditions, necessitates more surgical interventions, further propelling the demand for anastomosis devices. Key market players are actively engaging in product launches, mergers, and partnerships to enhance their offerings and expand their market presence, contributing to the overall growth trajectory of the industry.

North America is expected to hold a substantial share of the anastomosis devices market, supported by a robust regulatory framework and increasing awareness of surgical options for chronic conditions. The region's growth is further bolstered by the high incidence of cardiovascular disorders and obesity, leading to a rise in surgical procedures. The competitive landscape is characterized by the presence of both global and regional companies, with major players like Baxter, Medtronic, and Johnson & Johnson leading the market. Innovations such as the ECHELON+ Stapler and the Vesseal system are set to enhance surgical outcomes and drive market expansion. Despite challenges like the adoption of minimally invasive procedures and high treatment costs, the market is expected to grow steadily over the forecast period.

Explore More

Anastomosis Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rise in Number of Surgical Procedures like Colectomy, CABG and Others

      2. 1.2.2 Availability of Technologically Advanced Products and Reimbursement Policies

    3. 1.3 Market Restraints

      1. 1.3.1 Adoption of Minimally Invasive Procedures like Percutaneous Coronary Interventions

      2. 1.3.2 Highly Expensive Treatments and Lack of Advanced Healthcare Infrastructure

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Usage

      1. 2.1.1 Disposable

      2. 2.1.2 Reusable

    2. 2.2 By Type

      1. 2.2.1 Surgical Staplers

      2. 2.2.2 Surgical Sutures

      3. 2.2.3 Surgical Sealants and Adhesives

      4. 2.2.4 Other Types

    3. 2.3 By Application

      1. 2.3.1 Cardiovascular Surgery

      2. 2.3.2 Gastrointestinal Surgery

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United states

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Anastomosis Devices Market Size FAQs

The Global Anastomosis Devices Market is projected to register a CAGR of 7% during the forecast period (2024-2029)

Baxter International Inc. (Synovis Micro Companies Alliance, Inc.), Medtronic Plc, Getinge AB, Johnson & Johnson (Ethicon US, LLC.) and LivaNova PLC are the major companies operating in the Global Anastomosis Devices Market.

Anastomosis Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)